HUM Stock Analysis
HU
Avoid
Based on Eyestock quantitative analysis, HUM`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Humana Inc. is a health and well-being company. The Company operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. The Insurance segment also includes products consisting of employer group commercial fully-insured medical and specialty health. The CenterWell segment represents its payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The Company’s subsidiaries include Mid-South Home Health Agency, LLC, Premier Home Health Agency, LLC and Humana Regional Health Plan, Inc.